TradeUP Acquisition Corp. (UPTDU)
Chart Events
Performance Outlook
| Previous Close | 10.37 |
| Open | 10.30 |
| Bid | 10.25 x 1100 |
| Ask | 11.39 x 2900 |
| Day's Range | 10.28 - 10.30 |
| 52 Week Range | 9.51 - 10.77 |
| Volume | |
| Avg. Volume | 1,234 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company mush complete its initial business combination from January 19, 2023 to February 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such Extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511
- PR Newswire
Estrella Biopharma, Inc., a biopharmaceutical company to Become a Publicly Traded Company Via Merger with TradeUP Acquisition Corp.
Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics, and TradeUP Acquisition Corp. ("TradeUP") (NASDAQ: UPTD), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement on September 30, 2022 that will result in Estrella becoming a publicly listed company.
